Hossein Jamalirad, Mahdie Jajroudi, Bahareh Khajehpour, Mohammad Ali Sadighi Gilani, Saeid Eslami, Marjan Sabbaghian, Hassan Vakili Arki
{"title":"AI predictive models and advancements in microdissection testicular sperm extraction for non-obstructive azoospermia: a systematic scoping review.","authors":"Hossein Jamalirad, Mahdie Jajroudi, Bahareh Khajehpour, Mohammad Ali Sadighi Gilani, Saeid Eslami, Marjan Sabbaghian, Hassan Vakili Arki","doi":"10.1093/hropen/hoae070","DOIUrl":null,"url":null,"abstract":"<p><strong>Study question: </strong>How accurately can artificial intelligence (AI) models predict sperm retrieval in non-obstructive azoospermia (NOA) patients undergoing micro-testicular sperm extraction (m-TESE) surgery?</p><p><strong>Summary answer: </strong>AI predictive models hold significant promise in predicting successful sperm retrieval in NOA patients undergoing m-TESE, although limitations regarding variability of study designs, small sample sizes, and a lack of validation studies restrict the overall generalizability of studies in this area.</p><p><strong>What is known already: </strong>Previous studies have explored various predictors of successful sperm retrieval in m-TESE, including clinical and hormonal factors. However, no consistent predictive model has yet been established.</p><p><strong>Study design size duration: </strong>A comprehensive literature search was conducted following PRISMA-ScR guidelines, covering PubMed and Scopus databases from 2013 to 15 May 2024. Relevant English-language studies were identified using Medical Subject Headings (MeSH) terms. We also used PubMed's 'similar articles' and 'cited by' features for thorough bibliographic screening to ensure comprehensive coverage of relevant literature.</p><p><strong>Participants/materials setting methods: </strong>The review included studies on patients with NOA where AI-based models were used for predicting m-TESE outcomes, by incorporating clinical data, hormonal levels, histopathological evaluations, and genetic parameters. Various machine learning and deep learning techniques, including logistic regression, were employed. The Prediction Model Risk of Bias Assessment Tool (PROBAST) evaluated the bias in the studies, and their quality was assessed using the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) guidelines, ensuring robust reporting standards and methodological rigor.</p><p><strong>Main results and the role of chance: </strong>Out of 427 screened articles, 45 met the inclusion criteria, with most using logistic regression and machine learning to predict m-TESE outcomes. AI-based models demonstrated strong potential by integrating clinical, hormonal, and biological factors. However, limitations of the studies included small sample sizes, legal barriers, and challenges in generalizability and validation. While some studies featured larger, multicenter designs, many were constrained by sample size. Most studies had a low risk of bias in participant selection and outcome determination, and two-thirds were rated as low risk for predictor assessment, but the analysis methods varied.</p><p><strong>Limitations reasons for caution: </strong>The limitations of this review include the heterogeneity of the included research, potential publication bias and reliance on only two databases (PubMed and Scopus), which may limit the scope of the findings. Additionally, the absence of a meta-analysis prevents quantitative assessment of the consistency of models. Despite this, the review offers valuable insights into AI predictive models for m-TESE in NOA.</p><p><strong>Wider implications of the findings: </strong>The review highlights the potential of advanced AI techniques in predicting successful sperm retrieval for NOA patients undergoing m-TESE. By integrating clinical, hormonal, histopathological, and genetic factors, AI models can enhance decision-making and improve patient outcomes, reducing the number of unsuccessful procedures. However, to further enhance the precision and reliability of AI predictions in reproductive medicine, future studies should address current limitations by incorporating larger sample sizes and conducting prospective validation trials. This continued research and development is crucial for strengthening the applicability of AI models and ensuring broader clinical adoption.</p><p><strong>Study funding/competing interests: </strong>The authors would like to acknowledge Mashhad University of Medical Sciences, Mashhad, Iran, for financial support (Grant ID: 4020802). The authors declare no competing interests.</p><p><strong>Registration number: </strong>N/A.</p>","PeriodicalId":73264,"journal":{"name":"Human reproduction open","volume":"2025 1","pages":"hoae070"},"PeriodicalIF":8.3000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11700607/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human reproduction open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/hropen/hoae070","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Study question: How accurately can artificial intelligence (AI) models predict sperm retrieval in non-obstructive azoospermia (NOA) patients undergoing micro-testicular sperm extraction (m-TESE) surgery?
Summary answer: AI predictive models hold significant promise in predicting successful sperm retrieval in NOA patients undergoing m-TESE, although limitations regarding variability of study designs, small sample sizes, and a lack of validation studies restrict the overall generalizability of studies in this area.
What is known already: Previous studies have explored various predictors of successful sperm retrieval in m-TESE, including clinical and hormonal factors. However, no consistent predictive model has yet been established.
Study design size duration: A comprehensive literature search was conducted following PRISMA-ScR guidelines, covering PubMed and Scopus databases from 2013 to 15 May 2024. Relevant English-language studies were identified using Medical Subject Headings (MeSH) terms. We also used PubMed's 'similar articles' and 'cited by' features for thorough bibliographic screening to ensure comprehensive coverage of relevant literature.
Participants/materials setting methods: The review included studies on patients with NOA where AI-based models were used for predicting m-TESE outcomes, by incorporating clinical data, hormonal levels, histopathological evaluations, and genetic parameters. Various machine learning and deep learning techniques, including logistic regression, were employed. The Prediction Model Risk of Bias Assessment Tool (PROBAST) evaluated the bias in the studies, and their quality was assessed using the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) guidelines, ensuring robust reporting standards and methodological rigor.
Main results and the role of chance: Out of 427 screened articles, 45 met the inclusion criteria, with most using logistic regression and machine learning to predict m-TESE outcomes. AI-based models demonstrated strong potential by integrating clinical, hormonal, and biological factors. However, limitations of the studies included small sample sizes, legal barriers, and challenges in generalizability and validation. While some studies featured larger, multicenter designs, many were constrained by sample size. Most studies had a low risk of bias in participant selection and outcome determination, and two-thirds were rated as low risk for predictor assessment, but the analysis methods varied.
Limitations reasons for caution: The limitations of this review include the heterogeneity of the included research, potential publication bias and reliance on only two databases (PubMed and Scopus), which may limit the scope of the findings. Additionally, the absence of a meta-analysis prevents quantitative assessment of the consistency of models. Despite this, the review offers valuable insights into AI predictive models for m-TESE in NOA.
Wider implications of the findings: The review highlights the potential of advanced AI techniques in predicting successful sperm retrieval for NOA patients undergoing m-TESE. By integrating clinical, hormonal, histopathological, and genetic factors, AI models can enhance decision-making and improve patient outcomes, reducing the number of unsuccessful procedures. However, to further enhance the precision and reliability of AI predictions in reproductive medicine, future studies should address current limitations by incorporating larger sample sizes and conducting prospective validation trials. This continued research and development is crucial for strengthening the applicability of AI models and ensuring broader clinical adoption.
Study funding/competing interests: The authors would like to acknowledge Mashhad University of Medical Sciences, Mashhad, Iran, for financial support (Grant ID: 4020802). The authors declare no competing interests.
研究问题:人工智能(AI)模型预测接受微睾丸精子提取(m-TESE)手术的非阻塞性无精子症(NOA)患者的精子提取有多准确?摘要回答:人工智能预测模型在预测接受m-TESE的NOA患者成功取精方面具有重要的前景,尽管研究设计的可变性、小样本量和缺乏验证性研究等方面的局限性限制了该领域研究的总体可推广性。已知情况:先前的研究已经探索了m-TESE中成功取精的各种预测因素,包括临床和激素因素。然而,尚未建立一致的预测模型。研究设计规模持续时间:根据PRISMA-ScR指南进行全面的文献检索,涵盖PubMed和Scopus数据库,时间为2013年至2024年5月15日。使用医学主题标题(MeSH)术语确定相关的英语研究。我们还使用PubMed的“类似文章”和“被引用”特征进行全面的书目筛选,以确保全面覆盖相关文献。参与者/材料设置方法:本综述纳入了NOA患者的研究,其中基于人工智能的模型通过结合临床数据、激素水平、组织病理学评估和遗传参数来预测m-TESE结果。采用了各种机器学习和深度学习技术,包括逻辑回归。预测模型偏倚风险评估工具(PROBAST)评估了研究中的偏倚,并使用透明报告个体预后或诊断多变量预测模型(TRIPOD)指南对其质量进行了评估,以确保可靠的报告标准和方法的严谨性。主要结果和偶然性的作用:在筛选的427篇文章中,45篇符合纳入标准,其中大多数使用逻辑回归和机器学习来预测m-TESE结果。基于人工智能的模型通过整合临床、激素和生物因素显示出强大的潜力。然而,研究的局限性包括样本量小、法律障碍以及在推广和验证方面的挑战。虽然一些研究采用了更大的多中心设计,但许多研究受到样本量的限制。大多数研究在参与者选择和结果确定方面具有低偏倚风险,三分之二的研究在预测因子评估中被评为低风险,但分析方法各不相同。局限性:本综述的局限性包括纳入研究的异质性、潜在的发表偏倚以及仅依赖两个数据库(PubMed和Scopus),这可能会限制研究结果的范围。此外,缺乏荟萃分析妨碍了对模型一致性的定量评估。尽管如此,该综述为noaa中m-TESE的人工智能预测模型提供了有价值的见解。研究结果的更广泛意义:该综述强调了先进的人工智能技术在预测接受m-TESE的NOA患者成功取精方面的潜力。通过整合临床、激素、组织病理学和遗传因素,人工智能模型可以增强决策能力,改善患者预后,减少手术失败的次数。然而,为了进一步提高人工智能预测在生殖医学中的准确性和可靠性,未来的研究应通过纳入更大的样本量并进行前瞻性验证试验来解决当前的局限性。这种持续的研究和开发对于加强人工智能模型的适用性和确保更广泛的临床应用至关重要。研究经费/竞争利益:作者感谢伊朗马什哈德医学科学大学(Mashhad University of Medical Sciences, Mashhad, Iran)的资金支持(Grant ID: 4020802)。作者声明没有利益冲突。注册号:无。